DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Italy Healthcare Outlook Report, 2022
US$ 1,995.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Italy Healthcare Outlook 2022,” report provides comprehensive insights about healthcare scenario, regulatory policies and...
January 2022
60 pages
Japan Healthcare Outlook Report, 2022
US$ 1,995.00
This report can be delivered to the clients within 24 Hours Japan’s pharmaceutical market is one of the world’s biggest, with a value of around $95 billion, as per country’s Ministry of Health, Labo...
January 2022
60 pages
Kabuki Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Kabuki Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Keloid - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Keloid - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and...
January 2022
60 pages
Keratoconus - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Keratoconus - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Kidney Transplant Rejection - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Kidney Transplant Rejection - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...
January 2022
60 pages
Krabbe Disease - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Krabbe Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
KRAS Mutant Cancer - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'KRAS Mutant Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Lactose Intolerance - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Lactose Intolerance - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
LAG-3 Antagonist - Pipeline Insight, 2022
US$ 1,250.00
This report can be delivered to the clients within 48 hrs “LAG-3 Antagonist - Pipeline Insight, 2022” report by DelveInsight offers comprehensive insights of the pipeline (under development) therape...
January 2022
60 pages
Laron Syndrome (LS) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Laron Syndrome (LS) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Laryngeal Cancer - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Laryngeal Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...
January 2022
60 pages
Lassa Fever - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Lassa Fever - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Leber Congenital Amaurosis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Leber Congenital Amaurosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...
January 2022
60 pages
Leigh Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Leigh Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Leiomyosarcoma - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Leiomyosarcoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Lenegre's disease - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Lenegre's disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Lennox-Gastaut Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Lennox-Gastaut Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Leptomeningeal Metastases - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Leptomeningeal Metastases - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Lewy Body Disease - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Lewy Body Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Lice Infestations - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Lice Infestations - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Lichen Planus - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Lichen Planus - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...
January 2022
60 pages
